The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation

Key Points

• Improved tumor control is associated with dose homogeneity in breast hypofractionation, leading to better treatment outcomes.
• The analysis highlights evidence of improved outcomes concerning tumor control rates, emphasizing the significance of uniform dose delivery.
• Assessment using clinical outcomes demonstrates the necessity of maintaining dose homogeneity during breast hypofractionation treatments for effective therapy.
• These findings may encourage further research into optimizing treatment protocols, emphasizing the role dose homogeneity plays in patient care.